Autoimmune And Inflammatory Disorders Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Autoimmune and Inflammatory Disorders

Immune system protects the human body from disease and infection. However incase of autoimmune disease, immune system attacks healthy cells in the body by mistake. There are many systemic disorders with possible involvement of the nervous system with presumed inflammatory and autoimmune pathomechanisms. Abnormal inflammatory response is closely associated with in autoimmune diseases. These inflammations cause impaired functioning, resulting in neurological or psychiatric symptoms. Multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome are some of the most well known neurological diseases induced by abnormal autoimmunity.

The exact cause of immune-system misfire is unknown although some people are more likely to get an autoimmune disease than others. Certain autoimmune diseases, like multiple sclerosis and lupus is hereditary. Not every family member will necessarily have the disease, but they inherit a susceptibility to an autoimmune condition. As the incidence of autoimmune diseases is rising, researchers are also investigating environmental risk factors like infections and exposure to chemicals. Autoimmune disorders of the nervous system may affects both CNS and PNS, including the brain, spinal cord, peripheral nerves, neuromuscular junction and skeletal muscle.

Sub-track

Guillain-Barré syndrome
Autoimmune encephalitis
Myasthenia Gravis
NMO Spectrum Disease
Immune-Mediated Myopathies
Immune-Mediated Neuropathies
Novel Targeted Therapies for Autoimmune Diseases
Antigen-Specific Immunosuppression

Market Analysis: The global autoimmune disease therapeutics market was worth $109,833 million in 2017, and is expected to grow at a CAGR of 4.2 percent from 2018 to 2025, to reach $153,320 million. An autoimmune illness is a condition in which the immune system attacks and destroys its own body tissue. During the forecast period, the autoimmune disease diagnostics market is expected to grow at a CAGR of roughly 8.3%. Rising global awareness of autoimmune disorders as a result of research, education, support, and advocacy activities is a major reason driving up the use of autoimmune disease diagnostics. The global autoimmune disease diagnosis market is estimated to increase at a CAGR of 8.9% from USD 4.1 billion in 2020 to USD 6.3 billion in 2025. The global autoimmune disease therapeutics market was worth $109,833 million in 2017, and is expected to grow at a CAGR of 4.2 percent from 2018 to 2025, to reach $153,320 million. From 2018 to 2025, the global autoimmune disease treatments market is estimated to increase at a CAGR of 4.2 percent, from about $109.83 billion in 2017 to $153.32 billion in 2025.

Tracks